INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 15 apr 2023
Pagine: 57 - 71
DOI: https://doi.org/10.2478/inmed-2023-0238
Parole chiave
© 2023 Florin Mihălţan et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Tuberculosis has taken on a new face in the context of emergent drug use. The combination of conditions such as HIV infection, hepatitis B or C, arising from the use of injectable drugs create serious problems in hospitals. In this new context, the authors analyze epidemiological aspects, predisposing factors, clinical expressions and therapeutic solutions for these cases, but also the programs that must be adopted to allow the control of this new worldwide challenge.